Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Skulle Implants Oy
OY
Active
Y-tunnus 2416737-4
Lemminkäisenkatu 60, 20520
Turku
Technical testing and analysis
·
NACE 7120
Est. 2011 · 14 years old
10 employees
www.skulleimplants.com
Share
Finland
/
Companies
/
Technical testing and analysis
/
Skulle Implants Oy
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
JH
Juliusz Henrik Tadeusz Rakowski
Chief Executive Officer
Chief Executive Officer
2025
Former (4)
MH
Maija Helena Junkola-Lehtonen
Chief Executive Officer
Chief Executive Officer
2020 – 2022
TP
Tommi Petteri Brunila
Chief Executive Officer
Chief Executive Officer
2022 – 2025
MS
Matti Samuli Rantanen
Audit
Audit
2015 – 2022
KJ
Kalle Juhani Laaksonen
Audit
Audit
2022 – 2023
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (4)
HJ
Heikki Juhani Salmela
Board of Directors
Board of Directors
2026
JP
Johan Paul Löfgren
Board of Directors
Board of Directors
2023
OP
Olli Pekka Karhi
Board of Directors
Board of Directors
2026
PK
Pasi Kalevi Räty
Chairperson
Chairperson
2026
Former (9)
RJ
Roni Juha Kaunismaa
Board of Directors
Board of Directors
2022 – 2026
SK
Sakari Kalervo Kotka
Board of Directors
Board of Directors
2022 – 2022
JN
Juha-Pekka Nuutinen
Board of Directors
Board of Directors
2018 – 2019
HN
Hanna-Marika Nikkilä
Board of Directors
Board of Directors
2022 – 2023
PK
Pekka Kalevi Vallittu
Board of Directors
Board of Directors
2026 – 2026
JP
Jukka Petri Olavi Toivanen
Board of Directors
Board of Directors
2022 – 2022
LT
Lauri Tapio Sippola
Board of Directors
Board of Directors
2020 – 2022
ST
Sirpa Tuulikki Jalkanen
Board of Directors
Board of Directors
2020 – 2022
JO
Juha Olavi Reima
Chairperson
Chairperson
2022 – 2022
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Oy Skulle Group Corporation
Company
56%
56%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Skulle Implants Oy
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network